HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul Sator Selected Research
Paul Sator Research Topics
Disease
6
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 08/2018
1
Lichen Planus (Lichen Ruber Planus)
09/2022
1
Atopic Dermatitis (Atopic Eczema)
09/2022
1
Lichenoid Eruptions
09/2022
1
Hypersensitivity (Allergy)
10/2021
1
Infections
08/2018
1
Hepatitis B
08/2018
1
Neoplasms (Cancer)
08/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2018
1
Persistent Infection
08/2018
1
Tuberculosis (Tuberculoses)
08/2018
1
Injection Site Reaction
08/2018
1
Drug-Related Side Effects and Adverse Reactions
08/2018
Drug/Important Bio-Agent (IBA)
2
Adalimumab (Humira)
FDA Link
09/2022 - 08/2018
1
apremilast
IBA
01/2023
1
Phosphodiesterase 4 Inhibitors
IBA
01/2023
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
09/2022
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
09/2022
1
Antimalarials (Antimalarial Agents)
IBA
09/2022
1
Gold Sodium Thiomalate (Sodium Aurothiomalate)
IBA
09/2022
1
Etanercept (Enbrel)
FDA Link
09/2022
1
Infliximab (Remicade)
FDA Link
09/2022
1
dupilumab
IBA
09/2022
1
Methyldopa (Aldomet)
FDA Link
Generic
09/2022
1
Methotrexate (Mexate)
FDA Link
Generic
01/2022
1
Immunoglobulin E (IgE)
IBA
10/2021
1
Allergens
IBA
10/2021
1
Fumarates
IBA
10/2019
1
Dimethyl Fumarate
IBA
10/2019
Therapy/Procedure
3
Therapeutics
01/2023 - 08/2018
1
Phototherapy (Light Therapy)
09/2022
1
Biological Therapy
08/2018
1
Contraindications
08/2018